SLP
NASDAQ
$18.23
Simulations Plus Inc (SLP)
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling, simulation, and prediction of molecule properties using artificial intelligence and machine learning technology worldwide. The company is headquartered in Lancaster, California.
Sector:
Healthcare
Industry:
Health Information Services
Hold
Target: $17.25 (-5.38%)
Market Cap
$369M
Forward P/E
21.64
P/E Ratio
45.51
Free Cash Flow Yield
6.65%
Price Chart
Valuation
Market Cap$369M
P/E45.51
Forward P/E21.64
PEG9.88
P/S4.49
P/B2.65
Profitability
Total Revenue (TTM)$82M
Gross Profit (TTM)$52M
EBITDA$19M
Profit Margin16.3%
Operating Margin20.6%
EPS$0.40
Financial Health
Free Cash Flow Yield6.65%
Growth & Risk
EPS 5Y CAGR-8.85%
Revenue 5Y CAGR+10.90%
FCF 5Y CAGR+14.98%
Beta (5Y)0.87
Sharpe Ratio0.88